Form 4: Eastman Chemical Co Director James J. O'Brien Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director James J. O'Brien reports acquisition of phantom stock units through deferral of director's fees.
Summary
- James J. O'Brien, a director at Eastman Chemical Co, filed a Form 4 on October 09, 2024, reporting changes in beneficial ownership.
- The report details the acquisition of 277 phantom stock units on October 07, 2024, through the Directors' Deferred Compensation Plan.
- These units represent deferred director's fees that would have otherwise been paid in cash.
- O'Brien's total holdings include 15,640 phantom stock units, including 232 units credited since April 5, 2024, as hypothetical reinvestment of dividend equivalents.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to director compensation and stock ownership, common among publicly traded companies.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects director compensation.
Key Dates
| Date | Description |
|---|---|
| April 5, 2024 | Date from which 232 units were credited as hypothetical reinvestment of dividend equivalents. |
| October 07, 2024 | Date of transaction: acquisition of 277 phantom stock units. |
| October 09, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.